Related Experiment Video
Updated: Aug 29, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Role of a conserved membrane-embedded acidic residue in the multidrug transporter MdfA
Julia Adler1, Oded Lewinson, Eitan Bibi
1Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.
Abstract:
According to the current topology model of the Escherichia coli multidrug transporter MdfA, it contains a membrane-embedded negatively charged residue, Glu26, which was shown to play an important role in substrate recognition. To further elucidate the role of this substrate recognition determinant, various Glu26 replacements were characterized. Surprisingly, studies with neutral MdfA substrates showed that, unlike many enzymatic systems where the size and chemical properties of binding site residues are relatively defined, MdfA tolerates a variety of changes at position 26, including size, hydrophobicity, and charge. Moreover, although efficient transport of positively charged substrates requires a negative charge at position 26 (Glu or Asp), neutralization of this charge does not always abrogate the interaction of MdfA with cationic drugs, thus demonstrating that the negative charge does not play an essential role in the multidrug transport mechanism. Collectively, these results suggest a link between the broad substrate specificity profile of multidrug transporters and the structural and chemical promiscuity at their substrate recognition pockets.
Insights
The Escherichia coli multidrug transporter MdfA exhibits broad substrate specificity due to a flexible binding pocket. Changes to key residues like Glu26 demonstrate MdfA’s tolerance for diverse chemical properties, impacting drug transport.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The multidrug transporter MdfA from Escherichia coli plays a crucial role in effluxing various compounds.
- A negatively charged residue, Glutamate 26 (Glu26), is proposed to be vital for substrate recognition.
- Understanding residue roles is key to characterizing transporter mechanisms and specificity.
Purpose of the Study:
- To investigate the role of the Glu26 residue in the substrate recognition and transport mechanism of MdfA.
- To determine the impact of varying chemical properties at position 26 on MdfA's substrate specificity.
Main Methods:
- Site-directed mutagenesis was used to create various replacements for the Glu26 residue in MdfA.
- Transport assays were performed using neutral and positively charged substrates to characterize transporter activity.
- Analysis focused on the tolerance of MdfA to changes in size, hydrophobicity, and charge at position 26.
Main Results:
- MdfA demonstrated significant tolerance to diverse substitutions at position 26, including changes in size, hydrophobicity, and charge, for neutral substrates.
- While a negative charge at position 26 facilitates the transport of positively charged substrates, its absence did not always abolish interaction with cationic drugs.
- These findings challenge the notion of highly defined binding pockets in multidrug transporters.
Conclusions:
- The substrate recognition pocket of MdfA exhibits remarkable structural and chemical promiscuity.
- This flexibility in the binding site likely contributes to the broad substrate specificity observed in multidrug transporters.
- The role of specific charged residues in substrate binding may be less rigid than previously assumed.
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ABC Transporters: Exporter
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...

